Toray receives approval from China’s NMPA for Careload to treat pulmonary arterial hypertension

Toray

28 September 2022 - Toray Industries announced today that it has received approval from China’s NMPA for Careload tablets to treat pulmonary arterial hypertension. 

Careload is a proprietary orally administered sustained release formulation of beraprost sodium, a derivative of prostacyclin.

Read Toray press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , China